SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-19-269398
Filing Date
2019-10-17
Accepted
2019-10-18 09:22:38
Documents
2
Group Members
HEALTHCAP VII GP S.A.

Document Format Files

Seq Description Document Type Size
1 SC 13D d806432dsc13d.htm SC 13D 56621
2 EX-1 d806432dex1.htm EX-1 5415
  Complete submission text file 0001193125-19-269398.txt   63508
Mailing Address 18 AVENUE D'OUCHY CH 1006 LAUSANNE V8 1000-1018
Business Address 18 AVENUE D'OUCHY CH 1006 LAUSANNE V8 1000-1018 41 21 614 3500
HealthCap VII, L.P. (Filed by) CIK: 0001645161 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address 535 BOYLSTON STREET BOSTON MA 02116 6095104718
Aprea Therapeutics, Inc. (Subject) CIK: 0001781983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91159 | Film No.: 191156842
SIC: 2834 Pharmaceutical Preparations